ALB and cardiomyopathy: Patients that failed to achieve hemodynamic optimization goals exhibited increased 1-year mortality (HR 4.1, 95% CI 1.24–13.2, p = 0.02, Figure 2) adjusted for age, INTERMACS category, type of cardiomyopathy, creatinine, total bilirubin and albumin, compared with no RVD at baseline.